Back to Homepage

Laura M. McNamee

Adjunct Assistant Professor, Natural and Applied Sciences
Ph.D., University of Massachusetts Medical School, 2009
B.S., Merrimack College, 2003
Office: Lewis Hall 102 | 781.891._2935 |

Expand All
Collapse All


Journal Article(s)
Beierlein, J. M., McNamee, L. M., Walsh, M. J., Ledley, F. D. (2015). Patterns of Innovation in Alzheimer's Disease Drug Development: A Strategic Assessment Based on Technological Maturity. Clinical Therapeutics, 37 (8), 1643-1651. (link)

McNamee, L. M., Ledley, F. D. (2013). Assessing the history and value of Human Genome Sciences. . Journal of Commercial Biotechnology, 19 (4), 3-10. (link)

McNamee, L. M., Ledley, F. D. (2013). Making the biotech IPO work. Nature Biotechnology, 31, 969-970. (link)

Ledley, F. D., McNamee, L. M., Uzdil, V., Morgan, I. W. (2013). Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies . Gene Therapy. (link)

McNamee, L. M., Ledley, F. D. (2013). Translational science in the biotechnology industry; the impact of technological maturity. PLoS ONE, 8 (12), 7. (link)

McNamee, L. M., Ledley, F. D. (2012). Patterns of technological innovation in biotechnology.. Nature Biotechnology, 30 (10), 937-943. (link)

McNamee, L. M., Brodsky, M. H. (2009). p53-independent apoptosis limits DNA damage-induced aneuploidy. Genetics, 182 (2), 423-435.